Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Mallinckrodt
Colorcon
Johnson and Johnson
Medtronic

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

Litigation Details for Medicis Pharmaceutical Corporation v. Nycomed U.S., Inc (S.D.N.Y. 2011)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Medicis Pharmaceutical Corporation v. Nycomed U.S., Inc (S.D.N.Y. 2011)

Docket   Start Trial Date Filed 2011-07-19
Court District Court, S.D. New York Date Terminated 2012-07-19
Cause 35:145 Patent Infringement Assigned To Alison Julie Nathan
Jury Demand Both Referred To
Parties FOUGERA PHARMACEUTICALS INC.; MEDICIS PHARMACEUTICAL CORPORATION; NYCOMED U.S., INC
Patents 7,981,909
Attorneys Andrew M. Berdon; David Avrum Manspeizer; Peter James Shen; Robert Bradley Wilson
Firms Quinn Emanuel Urquhart & Sullivan, LLP (NYC); Wilmer Cutler Pickering Hale and Dorr LLP (NYC)
Link to Docket External link to docket
Small Molecule Drugs cited in Medicis Pharmaceutical Corporation v. Nycomed U.S., Inc
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Medicis Pharmaceutical Corporation v. Nycomed U.S., Inc (S.D.N.Y. 2011)

Date Filed Document No. Description Snippet Link To Document
2012-02-27 13 8. United States Patent No. 7,981,909 (“the ‘909 patent”), entitled “Use of 1- … This is a civil action for patent infringement arising under the patent laws of the United States… of the ‘909 patent is attached to the Complaint. 9. The ‘909 patent resulted from… issuance of the ‘909 patent, and as to invalid or unenforceable patent claims. …admits that Medicis purports to assert a claim for patent infringement, but specifically denies that Medicis External link to document
2012-07-19 21 infringement of United States Patent No. 7,981,909 ("the Medicis Patent"); WHEREAS Defendant…acknowledges and agrees that the claims of the Medicis Patent are valid and enforceable. 2. Except as reserved… and Settlement Agreement, infringe the Medicis Patent. 3. All claims and counterclaims in this action…litigation in this Court relating to the Medicis Patent and the Fougera Ciclopirox Product ("the Litigation…factual or legal findings with regard to the Medicis Patent or the Fougera Ciclopirox Product; WHEREAS External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
McKinsey
Colorcon
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.